logo

Curevac N.V. (CVAC)



Trade CVAC now with
  Date
  Headline
10/12/2021 7:18:27 AM CureVac To Withdraw 1st-generation COVID-19 Vaccine Candidate, CVnCoV From Approval Process With EMA
9/14/2021 7:30:10 AM CureVac Announces Decision To Adjust Long-term Footprint Of External European Network For MRNA Product Pipeline
8/31/2021 7:19:13 AM CureVac Publishes CVnCoV Phase 2b/3 Study Data In Preprints With The Lancet
8/30/2021 8:37:08 AM CureVac Preclinical Data Demonstrates Significant Reduction Of Liver Fibrosis With MRNA Therapeutic
8/16/2021 8:11:36 AM CureVac Says COVID-19 Vaccine Candidate, CV2CoV, Demonstrates Improved Immune Response In Preclinical Study
8/16/2021 8:09:49 AM CureVac Q2 Pre-tax Losses EUR 152.2 Mln Vs Loss EUR 12.0 Mln Last Year
6/30/2021 7:12:00 AM CureVac Appoints Malte Greune As COO, Effective July 1
6/23/2021 7:42:06 AM CureVac: Ingmar Hoerr Withdrawn His Candidacy For Nomination To Supervisory Board
6/16/2021 5:42:16 PM Stock Alert: CureVac Drops 50%
6/8/2021 11:00:16 AM Stock Alert: CureVac Slips 13%
6/2/2021 7:31:27 AM CureVac Appoints Klaus Edvardsen As Chief Development Officer